Market-Moving News for January 4th
Benzinga Newsdesk 2 years ago
MoversTrading Ideas
OMGA: 132% | Novo Nordisk Collaborates With Omega Therapeutics And Cellarity For Obesity, Metabolic Dysfunction-associated Steatohepatitis, Respectively; Novo Nordisk Will Reimburse R&D Costs, Each Company